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summary and conclusions
The polyamines, spermidine (Sd) and spermine (Sp),  and their  precursor pu-
trescine (Pu),  are components of al l  l iv ing cel ls.  The biological Íunct ions oÍ
the polyamines are related to their  unique cat ionic harge distr ibut ion. Polya-
mines modify the conformation and stability oÍ nucleic acids, the activÍty oÍ a
number oÍ regulatory enzymes, and the stabi l i ty of  membranes. Due to their
involvement in cel lgrowth, the str ict ly regulated biosynthesis oÍ polyamines
has been studied in detai l .  Relat ively l i t t le attent ion has been paid to their
degradation. Polyamines are catabolyzed by the action oÍ a multitude oÍ en-
zymes. The quantitatively most important deactivating pathways are N-acetyl
conjugat ion and subsequent or direct oxidat ive deaminat ion by var ious
amine oxidases.
Determinat ion oÍ polyamines in extracel lular Í lu ids is especial ly important Íor
est imating the extent oÍ chemo- and radiotherapeut ical ly induced tumor-cel l
death in cancer pat ients.  Surpr is ingly,  l i t t le attent ion has been paid to the ad-
ditional excrelion oÍ polyamine catabolites. The application oÍ polyamine
measurements is almost completely Íocussed on the parent amines and to a
lesser extent on their  monoacetylated conjugates. Both physiological  nd
pathophysiological conditions aÍÍect the activities oÍ the enzymes involved in
polyamine degradat ion. ln case polyamine xcret ion is used Íor diagnost ic
purposes, i t  seems imperat ive to take polyamine degradat ion into considera-
t i o n .
The aim oÍ this study is
to develop methods Íor the simutaneous determinat ion oÍ polyamines, lheir
conjugates and their  catabol i tes in extracel lular Í lu ids and erythrocytes,
to invest igate the catabol ic Íate of the polyamines and
to evaluate the cl in ical  useÍulness of extracel lular nd erythrocyte polya-
mines, especial ly their  metabol i tes, as general ly appl icable parameters of
( tumor) cel l  kenet ics and cel l lurnover.
In chapter 1 the development oÍ capillary gas-chromatographic methods Íor
the simultaneous determinat ion of polyamines and their  metabol i tes in di Í Íer-
ent body Íluids is described. With gas-chromatography and nitrogen-phos-
phorus detection we were enable to determine simultaneously total polya-
mines and some of their  catabol i tes in acid-hydrolyzed ur ine (1 .1),  and Íree
polyamines, their acelyl conjugates and some of their catabolites in unhydro-
lyzed ur ine (1.2).  Free polyamines in erythrocytes (RBCs) were determined
with a simi lar gas-chromatographic method (1 3 1) As the isolat ion method
oÍ RBCs was Íound to inÍ luence their  measured polyamine content,  a repro-
ducible method Íor their  isolat ion on a discont inuous histopaque gradient is
recommended (1.3.2).  An isotope di lut ion mass Íragmentographic method
was developed Íor the simultaneous quant i f icat ion oÍ the low (5-200 nmol/ l )
concentrations oÍ polyamines and some oÍ their catabolites in acid-hydro-
lyzed cerebrospinal Í lu id (1.4).  Qual i ty-control  data are given Íor al l  devel-
1 4 3
oped methods. Age-dependent 'normal' values and reÍerence levels Íor ap-
parently healthy persons have been established for al l  analytes determined
in acid-hydrolyzed and unhydrolyzed urine, and Íor RBCs. In addition we
have investigated circadian rhythmicity and mentrual-cycle-dependent iur-
nal variation in the excretion of total polyamines and catabolites. For unhy-
drolyzed'normal'urines th  percentage oÍ acetylation Íor al l  polyamines were
established. Follow-up curves obtained Íor patients with non-Hodgkin's lym-
phoma, melanoma nd astrocytoma during treatment with cytotoxic agents
are discussed with respect to the possible role oÍ extracellular polyamines in
the judgment oÍ the eÍíicacy of chemotherapeutic cancer treatment. Special
attention has been payed to lhe excretion oÍ polyamine catabolites and con-jugates. An, unti l  now, unknown conjugate oÍ Sp (N1,N12 diacetylated Sp,
abbreviated N1,N1zdiacSp) was identiÍ ied inurine oÍ patients with high grade
non-Hodgkin's lymphoma by comparing the respective mass spectra oÍ a de-
rivatized synthetic slandard and the compound in a derivatized urine extract
exhibit ing the appropriate r tention t ime.
In chapter 2 the catabolic Íate of stable isotopically labeled polyamines aÍter
their Í irst and second intraperitoneal injection i rats is described (2.1). Using
this approach itwas possible to elucidate the major in vivo polyamine catabol-
ic pathways. Employing mass Íragmentography at specific Íragment ions,
Íour of the newly discovered cataboli tes in rat urine, were subsequently
identiÍ ied innormal human urine, and in urines oÍ patients with non-Hodg-
kin's lymphoma and melanoma (2.2). l l lustrated by a Íol low-up of the concen-
trations oÍ polyamines and their catabolites inthe acid-hydrolyzed urines oÍ a
patient with high-grade non-Hodgkin's lymphoma during chemotherapy, the
catabolic pressure on polyamines during neoplastic diseases is discussed.
Relative to the excretion oÍ Sd, an even higher proportion oÍ the non-o-
amino acid catabolite of Sd, isoputreanine (lsoputr) was observed. Employ-
ing oÍ a developed isotope dilution mass Íragmentographic melhod, it was
shown that in normal unhydrolyzed human urine lsoputr is predominantly ex-
creted as N1 -acetylisoputreanine-y-lactam, whereas during successÍul che-
motherapy oÍ patients with stage lV non-Hodgkin's lymphoma other, as yet
unknown, forms oÍ conjugated lsoputr are excreted as well (2.3).
In chapter 3 some Íundamental studies are described employing the newly
developed gas chromatographic methods with nitrogen-phosphorus detec-
tion. In an effort o more clearly deÍine the metabolism and Íate oÍ the polya-
mines during alterations incell proliÍeration, differentiation, and cell loss, we
determined the concentrations oÍ polyamines, their conjugates and some of
their catabolites inamniotic íluid and urine oÍ women in the course of the
gestation (3.1). In the urine oÍ pregnant women monoacetylated Pu (acPu)
and Nl,Nl2diacSp were Íound to be the main excretory Íorms oÍ Pu and Sp,
respectively. Their urinary concentrations increase during pregnancy. AcPu
showed the highest levels at the end oÍ pregnancy, whereas N1,N1zdiacSp
reached its maximum at about he 32th week. AcPu and N1,N12diacSp were
the quantitatively most important polyamines inamniotic Íluid. The appear-
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rÍ luid. The appear-
ance of extracellular N1,N12diacSp su ports the hypothesis that unique con-
jugates may be produced under altered physiological circumstances
(pregnancy) and in speciÍic diseases (non-Hodgkin's lymphoma). The pro-
duction oÍ N1,N12diacSp may be dependent on the degree oÍ diÍÍerentiat ion,
coherent with maturation oÍ the FAD-dependent polyamine oxidase activity,
as newborns were Íound to excrete substantial mounts oÍ Nl,N12diacSp
during their Íirst month aÍter birth. Nl,Nl2diacsp is not detectable in urines oÍ
men and non-pregnant women by the presently used technique.
In an efÍort o deÍine more clearly the relation between RBC polyamines and
cell-age-distribution, we have determined their content in states character-
ized by increased erythropoiesis, increased RBC turnover, and in density-
separated RBCs (3.2). We performed measurements oÍ polyamines in RBCs
and urine obtained beÍore-, during- and after Írequent blood sampling Írom
rats, as well as in urines and RBCs Írom pediatric patients with homozygous
sickle cell anemia nd sickle-hemoglobin-C disease. In addition polyamines
were delermined in various Íractions oÍ density-separated RBCs Írom normal
healthy adults, a patient with microcytic anemia, and two patients with sickle
cell disease. The obtained ata showed that as the number oÍ reticulocytes
in a RBC population i creases, the RBC Sd plus Sp content increases.
There was a significant relation between the RBC Sd plus Sp content and
the number oÍ reticulocytes, when all RBC populations, oríractions oÍ them,
obtained Írom controls and patients are considered as a whole. However, lhe
residual standard eviation of this relationship was high, which may predomi-
nantly be caused by a variable amount oÍ RNA in reticulocytes.
in conclusion:
For the optimalization Í the clinical usefulness ofpolyamines as general
markers Íor tumor cell kinetics during chemotherapeutic treatment of patients
with neoplastic diseases the additional monitoring oÍ polyamlne conjugates,
catabolites and parameters Íor the description oÍ the patient-individual
'catabolic pressure'is recommendable. The latter may include the measure-
ment oÍ activities of circulating amine oxidases. As the polyamine contenl of
a RBC population isstrongly related to the number oÍ reticulocytes, en-
hanced RBC turnover should be taken into consideration when judging up-
take mechanism (carrier Íunction) oÍ RBCs in patients with neoplastic diseas-
es during chemotheÍapeutic treatment.
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